All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Fc receptor-like protein 5 is a protein that in humans is encoded by the FCRL5 gene. FCRL5 has also been designated as CD307 (cluster of differentiation 307). This gene encodes a member of the immunoglobulin receptor superfamily and the Fc-receptor like family. This gene and several other Fc receptor-like gene members are clustered on the long arm of chromosome 1. The encoded protein is a single-pass type I membrane protein and contains 8 immunoglobulin-like C2-type domains. This gene is implicated in B cell development and lymphomagenesis. Alternatively spliced transcript variants encoding different isoforms have been identified. FcRL5 was expressed at elevated levels on the surface of plasma cells from the bone marrow of patients diagnosed with multiple myeloma. This prevalence in multiple myeloma and narrow pattern of normal expression indicate that FcRL5 could be a target for antibody-based therapies for multiple myeloma.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LC205 | Anti-FcRL5 (XHM401) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM401 | Mouse | scFv-CD28-CD3ζ | Retroviral | T cell | ||
CAR-LC206 | Anti-FcRL5 (XHM402) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM402 | Mouse | scFv-CD28-CD3ζ | Retroviral | T cell | ||
CAR-LC207 | Anti-FcRL5 (XHM403) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM403 | Human | scFv-41BB-CD3ζ | Retroviral | T cell | ||
CAR-LC208 | Anti-FcRL5 (XHM404) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM404 | Human | scFv-41BB-CD3ζ | Retroviral | T cell | ||
CAR-LC209 | Anti-FcRL5 (XHM405) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM405 | Human | scFv-41BB-CD3ζ | Retroviral | T cell | ||
CAR-LC210 | Anti-FcRL5 (XHM406) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM406 | Mouse | scFv-41BB-CD3ζ | Retroviral | T cell | ||
CAR-LC211 | Anti-FcRL5 (XHM407) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM407 | Human | scFv-41BB-CD3ζ | Retroviral | T cell | ||
CAR-LC212 | Anti-FcRL5 (XHM408) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM408 | Human | scFv-41BB-CD3ζ | Retroviral | T cell | ||
CAR-LC213 | Anti-FcRL5 (XHM460 ) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM460 | Mouse | scFv-41BB-CD3ζ | Retroviral | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION